AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2008
Apr 2, 2008
30826_dirs_2008-04-02_6124db92-b0a0-49c7-b9f4-f1b4094e3b15.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2008-03-31
Reporting Person: Kelly William J (Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-03-31 | Common Stock | A | 5000 | $.01 | Acquired | 5000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-03-31 | Stock Option (right to purchase) | $4.82 | A | 100000 | Acquired | 2018-03-31 | Common Stock (100000) | Direct |
Footnotes
F1: Shares will vest 03/31/2009
F2: 20,000 shares exercisable at each of the following dates: 3/31/2009, 3/31/2010, 3/31/2011, 3/31/2012, 3/31/2013.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23